Evotec SE (EVO) Asset Writedowns and Impairment (2021)

Evotec SE (EVO) posted Asset Writedowns and Impairment of -$781.33 for Q4 2021, up 85.25% sequentially from -$5296.2 in Q3 2021.

Evotec SE (EVO) Asset Writedowns and Impairment (2021) Analysis & Trends

Evotec SE has reported Asset Writedowns and Impairment for 1 years, with the latest figure at -$781.33 in Q4 2021.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Haleon	44.51 Bn	43.55 Bn	-
2	Teva Pharmaceutical Industries	43.52 Bn	39.86 Bn	2.15 Bn
3	Zoetis	32.43 Bn	30.75 Bn	1.05 Bn
4	Takeda Pharmaceutical	28.63 Bn	22.83 Bn	5.10 Bn
5	United Therapeutics	21.87 Bn	19.21 Bn	683.80 Mn
6	Viatris	18.98 Bn	18.09 Bn	1.46 Bn
7	Neurocrine Biosciences	15.43 Bn	15.04 Bn	935.80 Mn
8	Elanco Animal Health	12.02 Bn	11.49 Bn	798.00 Mn
9	Dr Reddys Laboratories	10.14 Bn	9.98 Bn	-
10	Evotec SE	687.23 Mn	686.75 Mn	-

Download Data